Agios Pharmaceuticals, Inc.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Agios Pharmaceuticals, Inc.
Market volatility, persistently high valuations, inflation and interest rates are among the issues sidetracking broader M&A, experts say.
The third annual listing of In Vivo’s ‘Rising Leaders’ includes entrepreneurs and innovators from across the world who represent the next wave of creativity in health care.
Servier is trying again with Tibsovo in the EU, while Protalix is using June 2021 data to support its filing for pegunigalsidase, which the US regulator turned down last April.
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker